search for
Search
Search
About
Help
Web Service
Emicizumab for hemophilia A with inhibitors: effectiveness and value : final evidence report
Collection:
Health Policy and Services Research
Contributor(s):
Institute for Clinical and Economic Review, issuing body. New England Comparative Effectiveness Public Advisory Council, issuing body.
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 16, 2018
Language(s):
English
Format:
Text
Subject(s):
Antibodies, Bispecific -- therapeutic use
Antibodies, Monoclonal -- therapeutic use
Hemophilia A -- drug therapy
Antibodies, Bispecific -- adverse effects
Antibodies, Monoclonal -- adverse effects
Cost-Benefit Analysis
Treatment Outcome
Humans
United States
Genre(s):
Technical Report
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license.
(More information)
Extent:
1 online resource (1 PDF file (various pagings))
Illustrations:
Illustrations
NLM Unique ID:
101744955 (
See catalog record
)
Permanent Link:
http://resource.nlm.nih.gov/101744955
Download
PDF
Plain Text
Metadata (Dublin Core)